vialaudit does not currently earn affiliate commission from any compounding pharmacy. This may change; if it does, the relationship will be disclosed per-page.
Is Fifty410 legit?
Fifty410 is operating and surfaces credible public signals (composite 66/100), but we have not placed a first-hand consult yet — this is a public-data audit. Highest Trustpilot score in the v0 cohort (4.6–4.8 across ~4,000 reviews) and a markedly cleaner public-record paper trail than the Hallandale-routed brands. The thin paper trail is partly absence-of-evidence — partner roster beyond BPI is not disclosed. The signal table below shows what we verified and what is still open. Read the full audit for FDA history, state-board records, and licensure footprint.
Signal table
What works, what does not
- +Highest Trustpilot signal in the v0 cohort — 4.6–4.8 / 5 across approximately 4,000 reviews
- +Tier-2 leader on the r/tirzepatidecompound May 2026 monthly survey
- +Marketplace language explicitly states Fifty410 does not compound, manufacture, or distribute medications directly — accurate regulatory framing
- +Named BPI partnership on the published pricing tiers; no FDA action against BPI surfaced in the public-record pass for this audit
- +Per-plan pricing published explicitly ($133/mo program, $299/mo cash, $166/mo on the 3-month plan, $499 for the 12-week BPI plan, $1,099 for the 24-week BPI plan)
- −Partner-pharmacy roster beyond BPI is not publicly disclosed — the audit cannot verify quality on any non-BPI fill
- −Multi-month commitment structure (12-week and 24-week BPI plans) is a buyer-experience drag; cancellation friction inside the plan term has surfaced in some reviews
- −Document-upload-on-refill UX friction surfaced in some Trustpilot reviews
- −Named prescriber identity, NPI, and per-state medical licensure not published
- −Clean FDA record is partly absence-of-evidence — Fifty410's partner roster is shorter than Trillium's published roster, but the undisclosed portion of the roster is the blind spot, not a clean signal
What we mean by "legit"
For a 503A compounding pharmacy, "legit" is not a single yes-or-no signal. The composite is a weighted average across nine dimensions — state pharmacy licensure footprint, FDA inspection history, state-board enforcement, USP <797> sterility signals, prescriber quality, raw-material sourcing, price transparency, buyer experience, and buyer protection. Read the full rubric at /methodology/compounding.
For Fifty410 the audit is "public-data tier" — we aggregate pharmacy disclosures, FDA databases, state-board records, NPI registry data, and community signals. A first-hand consult is pending and this page will be upgraded when that lands.
FAQ
Is Fifty410 legit?
Fifty410 is operating and surfaces credible public signals (composite 66/100), but we have not placed a first-hand consult yet — this is a public-data audit. Highest Trustpilot score in the v0 cohort (4.6–4.8 across ~4,000 reviews) and a markedly cleaner public-record paper trail than the Hallandale-routed brands. The thin paper trail is partly absence-of-evidence — partner roster beyond BPI is not disclosed. The signal table below shows what we verified and what is still open. Read the full audit for FDA history, state-board records, and licensure footprint.
Is Fifty410 a real pharmacy?
Fifty410 (Fifty410 LLC) is a telehealth distributor that routes prescriptions to one or more dispensing pharmacy partners (BPI Labs). The dispensing entity holds the state pharmacy license — the brand you see at checkout is a marketing layer over the licensed pharmacy underneath.
What states is Fifty410 licensed in?
Fifty410 serves all 50 states. You can confirm any state's licensure directly through that state's Board of Pharmacy license-lookup tool.
Has Fifty410 had any FDA inspections?
No FDA actions are on record (public databases as of 2026-05-24) for Fifty410. Absence of a 483 or warning letter is not the same as a sterility audit — the FDA inspects 503A pharmacies on a complaint-driven and risk-based cycle, not annually.
Has vialaudit placed a consult with Fifty410?
Not yet. Fifty410 is currently a public-data audit. We aggregate pharmacy disclosures, FDA inspection databases, state-board enforcement records, NPI registry data, and community signals. A first-hand consult is pending — this page upgrades when that lands.
How does Fifty410 compare to other compounding pharmacies?
Fifty410's composite is 66/100. The composite is weighted across nine dimensions — licensure, FDA history, state enforcement, sterility, prescriber, sourcing, price transparency, buyer experience, and buyer protection. See /pharmacies for the full leaderboard and /methodology/compounding for the rubric.
Verdict
Highest Trustpilot score in the v0 cohort (4.6–4.8 across ~4,000 reviews) and a markedly cleaner public-record paper trail than the Hallandale-routed brands. The thin paper trail is partly absence-of-evidence — partner roster beyond BPI is not disclosed.
Other audited pharmacies
Sources
- [01]Fifty410 homepage· vendor
- [02]Fifty410 — Trustpilot profile· Trustpilot
- [03]FDA — Compounding inspections, recalls, and other actions· FDA
- [04]r/tirzepatidecompound May 2026 telehealth & pharmacy survey· Reddit community survey
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.